Antibiotico-resistenza e antibiotico-sensibilità: bibliografia per breakpoint MIC

Elenco dei riferimenti bibliografici dei break point applicati per l’interpretazione dei dati delle MIC in Istituto Zooprofilattico Sperimentale delle Venezie.

Ultimo aggiornamento: 19 dicembre 2022.

Abbreviazione sul rapporto di prova Riferimento bibliografico
Aarestrup et al., 2002 Aarestrup FM., Butaye P., Witte W. 2002. Nonhuman Reservoirs of Enterococci. In “The Enterococci: Pathogenesis, Molecular Biology, and Antibiotic Resistance”. Edited by S. Gilmore et al., ASM Press, Washingthon DC, 20036, 2904.
Bakum Break point adottati presso il Laboratorio Diagnostico Veterinario di Bakum, Università di Hannover, Germania.
Beheraham et al., 2008 Behbahan NGG, Asaki K, Afsharifar AR, Pourbakhsh SA.  Susceptibilities of Mycoplasma gallisepticum and Mycoplasma synoviae isolates to antimicrobial agents in vitro. Int J Poul Sci. 2008;7(11): 1058-1064.
CA-SFM/CASFM 2019/CASFM VET 2019 Break point suggeriti dalla Società Francese di Microbiologia in ambito veterinario. https://www.sfm-microbiologie.org/wp-content/uploads/2019/01/CASFM_VET2018.pdf
CA-SFM EUCAST/CASFM-H Break points suggeriti in umana dalla Società Francese di Microbiologia e approvati da EUCAST. https://www.sfm-microbiologie.org/wp-content/uploads/2019/02/CASFM2019_V1.0.pdf
CASFM_VET 2020/ CASFM 2020 VERS 1.2 OTT 2020/ CA-SFM/EUCAST vers 1.2 (10/2020) Break point suggeriti dalla Società Francese di Microbiologia in ambito veterinario. https://www.sfm-microbiologie.org/wp-content/uploads/2020/09/CASFM_VET2020
CLSI, 2008 Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria isolated from animals. 1st ed. CLSI document VET 06. Wayne, PA: Clinical and Laboratory Standards Institute; 2017.
CLSI, 2008 Clinical and Laboratory Standards Insistute (CLSI), 2008. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated from Animals: Approved Standard, In: CLSI Document M31-A3. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
CLSI-H Break point per microrganismi isolati dall’uomo presenti nel manuale CLSI M100 S23, 2013.
CLSI-H M100/CLSI –H on line/CLSI M100 Manuale CLSI M100, M60, M27M44S, M23 consultabili on line al link em100.edaptivedocs.net
CLSI M 100 ED 2021 ED 31 Manuale CLSI M100 consultabile on line all’indirizzo:          http://em100.edaptivedocs.net/GetDoc.aspx?doc=CLSI%20M100%20ED31:2021
CLSI-V Manuale CLSI VET01S – Performance standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals
CLSI V01s ed 5:2020 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 5th Edition http://clsivet.org/GetDoc.aspx?doc=CLSI%20VET01S%20ED5:2020
CLSI-V HD Break point applicati in umana e suggeriti per microrganismi animali nel Manuale CLSI VET01-S2i. Performance standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals
CLSI-V HD on line Break applicati in umana e suggeriti per microrganismi animali nel Manuale CLSI VET01S, ED5:2020. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 5th Edition. http://clsivet.org
CLSI VET 01 S ED 5 2020 HUMAN Break applicati in umana e suggeriti per microrganismi animali nel Manuale CLSI VET01S, ED 5:2020. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 5th Edition. http://clsivet.org
CLSI-V on line Manuale CLSI VET01S, ED5:2020. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 5th Edition. http://clsivet.org
CLSI Vet08/CLSI V 08 Manuale CLSI VET08, ED4:2018. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals, 4th Edition. http://clsivet.org
CLSI-VF/CLSI Vet06, 2017/ CLSI VET06 ed 1/ CLSI VET 06 ED 2017 ED 1ST Manuale CLSI VET06 – Method for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria isolated from animals
CLSI-VF HD Break point applicati in umana e suggeriti per microrganismi animali nel Manuale CLSI VET06 – Method for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria isolated from animals
CRAB https://www.izslt.it/crab/wp-content/uploads/sites/8/2018/08/Tabelle-Resistenze-intrinseche-in-batteri-di-interesse-veterinario.pdf
De Jong et al., 2014 De Jong,A.,Thomas,V.,Simjee,S.,Moyaert,H.,ElGarch,F.,&Maher,K.(2014). Antimicrobial susceptibility monitoring of respiratory tract pathogens isolated from diseased cattle and pigs across Europe: The VetPath study. Veterinary Microbiology, 172(1–2), 202–215. https://doi.org/10.1016/J.VETMIC.2014.04.008
ECOFF IZSVe-Tv/dati IZS-Tv Break point epidemiologici individuati attraverso studi di antimicrobico-sensibilità condotti presso la Sezione di Treviso dell’IZSVe.
EUCAST/ EUCAST uomo v.10.0/ EUCAST  WERS 11.0, 2021/EUCAST v8.0/EUCAST -H Break point suggeriti da EUCAST. https://mic.eucast.org
EUCAST ECOFF Break point epidemiologici suggeriti da EUCAST. https://mic.eucast.org
FEBLER 2012 Feßler A.T., Kaspar H., Lindeman C.J., Stegemann M.R., Peters T., Mankertz J., Watts J.L., Schwarz S. .2012.A proposal of interpretive criteria for cefoperazone applicable to bovine mastitis pathogens. Veterinary Microbiology 157 (2012) 226–231.
Ganiere et al., 2005 Ganiere, J.-.-P., Medaille, C. and Mangion, C. (2005), Antimicrobial Drug Susceptibility of Staphylococcus intermedius Clinical Isolates from Canine Pyoderma. Journal of Veterinary Medicine, Series B, 52: 25-31. https://doi.org/10.1111/j.1439-0450.2004.00816.x
Gautier-Bouchardon, 2000 Gautier-Bouchardon AV1, Reinhardt AK, Kobisch M, Kempf I. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae. Vet Microbiol. 2002 Aug 2;88(1):47-58.
Hannan et al., 1997 Hannan PCT, Windsor GD, de Jong A, Schmeer N, Stegemann H. Comparative susceptibilities of various animal-pathogenic mycoplasmas to fluoroquinolones. Antimicrob Agents Chemoter. 1997;41: 2037-2040.
Kempf et al., 1989 Kempf I, Ollivier C, Guittet M, Morin Y, Bennejean G. Efficacité de la spiramycine et de la tylosine pour la prévention de la mycoplasmose chez des poussins expérimentalement infectés par Mycoplasma gallisepticum [Efficacy of spiramycin and tylosin in preventing mycoplasmosis in chicks experimentally infected with mycoplasma gallisepticum]. Pathol Biol (Paris). 1989;37(5 Pt 2):560–564.
LAM Simjee S., Amedeo J., Barletta A.M., Pridmore A. 2011. Use of Tylan 200 for the treatment of Mastitis caused by Staphylococcus aureus and/or Streptococcus uberis. In Udder health and communication – Ed. Hogaveen, Lam.
NCCLS Guidelines, 1997 National Committee for Clinical Laboratory Standards (NCCLS) Performance standards for antimicrobial susceptibility testing (1997)
Pedersen K. et al., 2007 Karl Pedersen, Kristina Pedersen, Helene Jensen, Kai Finster, Vibeke F. Jensen, Ole E. Heuer; Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs, Journal of Antimicrobial Chemotherapy, Volume 60, Issue 4, 1 October 2007, Pages 775–781, https://doi.org/10.1093/jac/dkm269
Pringle et al., 2012 Antimicrobial susceptibility of porcine Brachyspira hyodysenteriae and Brachyspira pilosicoli isolated in Sweden between 1990 and 2010
Ronne H. and Szancher J., 1990 Rønne, H., Szancer, J., 1990. Proceedings of the International PigVeterinary Society Congress, Lausanne, Switzerland. p. 126
Santos et al., 2010 Santos, T. M. A., L. S. Caixeta, V. S. Machado, A. K. Rauf, R. O. Gilbert, and R. C. Bicalho. 2010a. Antimicrobial resistance and presence of virulence factor genes in Arcanobacterium pyogenes isolated from the uterus of postpartum dairy cows. Vet. Microbiol. 145:84–8
Ter Laak et al., 1991 Ter Laak EA, Pijpers A, Noordergraaf JH, Schoevers EC, Verheijden JH. Comparison of methods for in vitro testing of susceptibility of porcine Mycoplasma species to antimicrobial agents. Antimicrob Agents Chemother. 1991;35(2):228–233. doi:10.1128/aac.35.2.228
USDA Break point suggeriti da USDA. https://www.ars.usda.gov/ARSUserFiles/60400520/NARMS/ABXEntero.pdf
Wang et al., 2008 Wang Y., Wu C.M., Lu L. M., Na Ren G.W., Cao X.Y., Shen J.Z. 2008. Macrolide–lincosamide-resistant phenotypes and genotypes of Staphylococcus aureus isolated from bovine clinical mastitis. Vet. Mic., 130 (1–2):118-125.
Wisselink et al., 2006 Wisselink,H.J., Veldman, K.T., Van den Eede, C., Salmon, S.A., Mevius, D.J., 2006.Quantitative susceptibility of Streptococcus suis strains isolated from diseased pigs inseven European countries to antimicrobial agents licensed in veterinary medicine.Vet. Microbiol. 113, 73–82.